- Home
- PRGO vs VIRT Comparison
PRGO vs VIRT Comparison
Compare PRGO & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- VIRT
- Stock Information
- Founded
- PRGO 1887
- VIRT 2008
- Country
- PRGO Ireland
- VIRT United States
- Employees
- PRGO 9140
- VIRT N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- VIRT Investment Bankers/Brokers/Service
- Sector
- PRGO Health Care
- VIRT Finance
- Exchange
- PRGO Nasdaq
- VIRT Nasdaq
- Market Cap
- PRGO 3.5B
- VIRT N/A
- IPO Year
- PRGO 1991
- VIRT 2015
- Fundamental
- Price
- PRGO $25.76
- VIRT $35.41
- Analyst Decision
- PRGO Buy
- VIRT Buy
- Analyst Count
- PRGO 4
- VIRT 7
- Target Price
- PRGO $37.00
- VIRT $29.50
- AVG Volume (30 Days)
- PRGO 1.3M
- VIRT 947.9K
- Earning Date
- PRGO 11-06-2024
- VIRT 01-23-2025
- Dividend Yield
- PRGO 4.29%
- VIRT 2.71%
- EPS Growth
- PRGO N/A
- VIRT 23.01
- EPS
- PRGO N/A
- VIRT 1.98
- Revenue
- PRGO $4,392,000,000.00
- VIRT $1,910,017,000.00
- Revenue This Year
- PRGO N/A
- VIRT N/A
- Revenue Next Year
- PRGO $4.51
- VIRT $2.12
- P/E Ratio
- PRGO N/A
- VIRT $17.85
- Revenue Growth
- PRGO N/A
- VIRT 10.60
- 52 Week Low
- PRGO $23.89
- VIRT $16.02
- 52 Week High
- PRGO $34.60
- VIRT $38.45
- Technical
- Relative Strength Index (RSI)
- PRGO 36.42
- VIRT 47.55
- Support Level
- PRGO $25.16
- VIRT $36.13
- Resistance Level
- PRGO $28.62
- VIRT $37.96
- Average True Range (ATR)
- PRGO 0.66
- VIRT 1.03
- MACD
- PRGO -0.35
- VIRT -0.37
- Stochastic Oscillator
- PRGO 15.79
- VIRT 30.81
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.